References:
1. PH, L. and K, F. (1990). A six-year clinical study of therapy of cardiomyopathy with coenzyme Q10. International Journal of Tissue Reactions, 12(3), pp.169-171.
2. Garrido-Maraver, J., D.Cordero, M., Orapesa-Avila, M., Fernandez Vega, A., Mata, M., Delgado Pavon, A., De Miguel, M., Perez Calero, C., Villanueva Paz, M., Cotan, D. and A.Sanchez Alcazar, J. (2014). Coenzyme Q10 Therapy. Molecular Syndromology, 5, pp.187-197.
3. DiNicolantonio, J., Bhutani, J., McCarty, M. and O’Keefe, J. (2015). Coenzyme Q10 for the treatment of heart failure: a review of the literature. Open Heart, 2(1), p.e000326.
4. Fedacko, J. (2011). Coenzyme Q10 in Heart and Brain Diseases. The Open Nutraceuticals Journal, 4(1), pp.69-87.
5. Niklowitz, P., Sonnenschein, A., Janetzky, B., Andler, W. and Menke, T. (2007). Enrichment of coenzyme Q10 in plasma and blood cells: defense against oxidative damage. International Journal of Biological Sciences, pp.257-262.
6. Oleck, S. and Ventura, H. (2016). Coenzyme Q10 and Utility in Heart Failure: Just Another Supplement?. Current Heart Failure Reports, 13(4), pp.190-195.
7. Bi, D., Chen, G., Cheng, J., Wen, J., Pei, N., Zeng, H., & Li, Y. (2020). Boswellic acid captivated hydroxyapatite carboxymethyl cellulose composites for the enhancement of chondrocytes in cartilage repair. Arabian Journal Of Chemistry. doi : 10.1016/j.arabjc.2020.03.030
8. Rashan , L., Hakkim , F., Idrees, M., Essa, M., Velusamy , T., & Al Baloshi , M. et al. (2019). Boswellia Gum Resin and Essential Oils: Potential Health Benefits − An Evidence Based Review. International Journal Of Nutrition,
Pharmacology, Neurological Diseases , 9 (2), 53. doi : 10.4103/ijnpnd.ijnpnd_11_19
9. Delshad , E., Yousefi , M., Sasannezhad , P., Rakhshandeh , H., & Ayati , Z. (2018). Medical uses of Carthamus tinctorius L. (Safflower): a comprehensive review from Traditional Medicine to Modern Med icine. Electronic Physician, 10 (4), 6672 6681. doi : 10.19082/6672